WebSep 16, 2024 · BioClonetics is in the final stage of development of a parent monoclonal antibody ("mAbs") (designated as Clone 3), which is non-toxic and has shown in initial … WebNov 16, 2024 · BioClonetics Immunotherapeutics, Inc. is a Dallas Texas biotech company with proprietary technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases including HIV, …
Gaurav Chandra MD,MBA - Chief Operating Officer
Web- BioClonetics - Equity Crowdfunding Campaign Co-Founder, Daily Deals for Moms * SOLD 2012 * - Hyper-local deals on services and experiences and products WebAssignee: BioClonetics Inventor: Joseph P. Cotropia Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) Patent number: 5777074 Abstract: A method for neutralizing HIV-1 is disclosed. A preferred embodiment utilizes a novel human monoclonal antibody that binds to a ... five seasons salon and spa dayton ohio
Enzolytics, Inc. Announces Execution of Letter of Intent with ...
WebDec 1, 2024 · BioClonetics Immunotherapeutics, Inc. is a Dallas, Texas biotech company with proprietary technology for producing fully human monoclonal antibodies … WebI had the pleasure of interviewing Charles Cotropia, CEO and co-founder of BioClonetics Immunotherapeutics, Inc. www.bioclonetics.com a Texas based biotech company. Thank you so much for joining us! Can you tell us a story about what brought you to this specific career path? My educational background is in Law and Aerospace Engineering. WebBioClonetics' antibody-based immunotherapeutics platform can be utilized across both human and animal infectious-disease applications. For example, the technology can be used to produce treatment for … can i use nasal inhaler when pregnant